NYSE Euronext today announced the listing of Intrasense, a key European publisher of software used in radiology diagnostics, on NYSE Alternext in Paris.

Founded in 2004, with offices in Montpellier, Paris and Shanghai, Intrasense designs, develops and markets Myrian^®, an advanced software suite used by experts to analyse medical images in three dimensions. This pioneering system is an invaluable aid to radiologists, surgeons and clinicians, who use it to ensure accurate diagnosis, plan therapy, and track certain pathologies, notably tumors. Intrasense has 44 employees, all bilingual and with a strong international focus, who work in either Research & Development or in marketing.

Intrasense (ticker code: ALINS) was listed through the admission to trading of 2,152,020 existing shares and 571,561 shares (of which 523,941 new shares) issued under a Global Offering[1], including full exercise of the extension clause and the partial exercise of the Over-allotment Option. The Global Offering raised a total of €4.2 million.

The admission and issue price of Intrasense shares was set at €7.40. Market capitalisation stood at around €21 million on the day of listing.

“We are delighted with Intrasense’s successful listing on NYSE Alternext – this year’s first on our market with lighter regulatory requirements that is tailor-made for SMEs. Intrasense is also the third company in the health sector to join us in just a few days” said Marc Lefèvre, Head of European Coverage at NYSE Euronext. “Listing is a milestone that will raise the company’s profile with investors and generate the financing it needs to step up its growth and continue building an efficient international distribution network,” he noted.

Intrasense Chairman Stéphane Chemouny and CEO Patrick Mayette added: “We are very pleased to be the first listing of the year on NYSE Alternext, joining the group of high-growth companies that have turned to the market to finance their development. We would like to take this opportunity to thank our employees, whose dedication adds value to Intrasense technology every day, as well as all the shareholders who have enabled us to list today and gain access to the resources we need to deploy our international strategy. As you now know, Intrasense is a core player in France’s fast-moving medical imaging industry. Our aim is to shape the industry as it advances.

In six years, €2.6 billion has been raised on NYSE Alternext, half through secondary issues, by companies from countries including Belgium, Canada, China, France, Italy, Luxembourg, the Netherlands, Spain, the UK and the US. Their market capitalization totals €5.9 billion. There are currently 180 companies listed on NYSE Alternext.

[1] The Global Offering was made up of an Open Price Public Offering and a Global Placement with institutional investors in France and other countries.